Interferon MonotherapyGreater Efficacy in Children?

• Younger age

• Earlier stage of liver disease

• Different modes of acquisition

• Higher relative interferon dose

• Lack of co-morbid factors

• Artifact

Previous slide

Next slide

Back to first slide

View graphic version